The Embarrassment of Riches: Combining SGLT2 Inhibitors and Nonsteroidal Mineralocorticoid Antagonists for the Treatment of Diabetic Kidney Disease

被引：0
|
作者：
Haller, Hermann [1 ,2 ]
机构：
[1] Mt Desert Biol Lab, Bar Harbor, ME 04609 USA
[2] Hannover Med Sch Hannover, Hannover, Germany
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2021年 / 52卷 / 08期
关键词：
SGLT2; inhibitors; Kidney; Diabetes; Nephropathy; EMPAGLIFLOZIN;
D O I：
10.1159/000516214
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：605 / 607
页数：3
相关论文
共 50 条
  • [31] Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease
    Yao, Lan
    Liang, Xianhui
    Wang, Pei
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2023, 324 (06): : E531 - E541
  • [32] Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
    Mende, Christian W.
    [J]. ADVANCES IN THERAPY, 2022, 39 (01) : 148 - 164
  • [33] Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
    Christian W. Mende
    [J]. Advances in Therapy, 2022, 39 : 148 - 164
  • [34] Diabetic ketoacidosis with SGLT2 inhibitors
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [35] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [36] SGLT2 inhibitors: β blockers for the kidney?
    Gilbert, Richard E.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (10): : 814 - 814
  • [37] SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
    Kanduri, Swetha R.
    Kovvuru, Karthik
    Hansrivijit, Panupong
    Thongprayoon, Charat
    Vallabhajosyula, Saraschandra
    Pivovarova, Aleksandra I.
    Chewcharat, Api
    Garla, Vishnu
    Medaura, Juan
    Cheungpasitporn, Wisit
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09)
  • [38] SGLT2 Inhibitors slow the Progression of chronic Kidney Disease
    不详
    [J]. DIABETOLOGE, 2019, 15 (06): : 567 - 567
  • [39] Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia
    Durcan, Emre
    Ozkan, Serbay
    Saygi, Halil Ibrahim
    Dincer, Mevlut Tamer
    Korkmaz, Ozge Polat
    Sahin, Serdar
    Karaca, Cebrail
    Sulu, Cem
    Bakir, Alev
    Ozkaya, Hande Mefkure
    Trabulus, Sinan
    Guzel, Elif
    Seyahi, Nurhan
    Gonen, Mustafa Sait
    [J]. JOURNAL OF DIABETES, 2022, 14 (04) : 236 - 246
  • [40] Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
    Su Jin Jeong
    Seung Eun Lee
    Dong Hyun Shin
    Ie Byung Park
    Hui Seung Lee
    Kyoung-Ah Kim
    [J]. BMC Nephrology, 22
12345